Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chaperonin-Containing TCP1 Complex (CCT) Promotes Breast Cancer Growth Through Correlations With Key Cell Cycle Regulators
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-30
DOI
10.3389/fonc.2021.663877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K inhibitors curtail MYC-dependent mutant p53 gain-of-function in head and neck squamous cell carcinoma
- (2020) Federica Ganci et al. CLINICAL CANCER RESEARCH
- Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis
- (2020) Anne E. Showalter et al. Scientific Reports
- The application and prospect of CDK4/6 inhibitors in malignant solid tumors
- (2020) Qi Du et al. Journal of Hematology & Oncology
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells
- (2020) Gang Xu et al. Cancer Cell International
- A review of retroperitoneal liposarcoma genomics
- (2020) Robert Tyler et al. CANCER TREATMENT REVIEWS
- Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
- (2020) Zhaoming Huang et al. OncoTargets and Therapy
- Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation
- (2020) Hongbo Qu et al. Frontiers in Oncology
- Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
- (2020) Zhen Li et al. Frontiers in Pharmacology
- MYC Oncogene Contributions to Release of Cell Cycle Brakes
- (2019) Lucía García-Gutiérrez et al. Genes
- Comprehensive in vivo identification of the c-Myc mRNA interactome using HyPR-MS
- (2019) Michele Spiniello et al. RNA
- Cdc20 and molecular chaperone CCT2 and CCT5 are required for the Muscovy duck reovirus p10.8-induced cell cycle arrest and apoptosis
- (2019) Quanxi Wang et al. VETERINARY MICROBIOLOGY
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- The substrate specificity of eukaryotic cytosolic chaperonin CCT
- (2018) Keith R. Willison PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of the molecular chaperone CCT in protein folding and mediation of cytoskeleton-associated processes: implications for cancer cell biology
- (2018) Josefine Vallin et al. CELL STRESS & CHAPERONES
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- E-cadherin, actin, microtubules and FAK dominate different spheroid formation phases and important elements of tissue integrity
- (2018) I. Smyrek et al. Biology Open
- Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer
- (2017) Ana C. Carr et al. Oncotarget
- PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
- (2017) Orielyz Flores et al. Theranostics
- Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide
- (2016) R. Bassiouni et al. CLINICAL CANCER RESEARCH
- The interactome of CCT complex – A computational analysis
- (2016) Aswathy Narayanan et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT–mTOR–S6K signaling and drug responses
- (2016) Angelika Riedl et al. JOURNAL OF CELL SCIENCE
- Staggered ATP binding mechanism of eukaryotic chaperonin TRiC (CCT) revealed through high-resolution cryo-EM
- (2016) Yunxiang Zang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Spheroid-based 3-dimensional culture models: Gene expression and functionality in head and neck cancer
- (2016) MARIANNE SCHMIDT et al. ONCOLOGY REPORTS
- Staggered ATP binding mechanism of eukaryotic chaperonin TRiC (CCT) revealed through high-resolution cryo-EM
- (2016) Yunxiang Zang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Myc and cell cycle control
- (2015) Gabriel Bretones et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes
- (2015) Stephen T. Guest et al. EXPERIMENTAL CELL RESEARCH
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells
- (2014) SHAO-HUA WANG et al. Molecular Medicine Reports
- The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption
- (2014) M W Lee et al. Cell Death & Disease
- Reversal of Anchorage-Independent Multicellular Spheroid into a Monolayer Mimics a Metastatic Model
- (2014) Rani Kunjithapatham et al. Scientific Reports
- Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
- (2014) Moses Kasembeli et al. PLOS BIOLOGY
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- Interaction of p53 with the CCT Complex Promotes Protein Folding and Wild-Type p53 Activity
- (2013) Antonio Garcia Trinidad et al. MOLECULAR CELL
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer
- (2012) Kenny Chitcholtan et al. EXPERIMENTAL CELL RESEARCH
- Rational Development of a Cytotoxic Peptide To Trigger Cell Death
- (2012) Rebecca J. Boohaker et al. MOLECULAR PHARMACEUTICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
- (2010) N. Turner et al. CANCER RESEARCH
- Intracellular -Tubulin/Chaperonin Containing TCP1- Complex Serves as a Novel Chemotherapeutic Target against Drug-Resistant Tumors
- (2009) Y.-F. Lin et al. CANCER RESEARCH
- On the role of the chaperonin CCT in the just-in-time assembly process of APC/CCdc20
- (2009) Carien Dekker FEBS LETTERS
- MYC in breast tumor progression
- (2008) Yinghua Chen et al. Expert Review of Anticancer Therapy
- Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies
- (2008) Alice Y Yam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started